Conjugate comprising an Antibody anti CCR5 and one or more peptides antifusogenicos; Pharmaceutical composition that comprises; Preparation method; and its use to treat Viral Infections.

摘要

The current invention is related to a conjugate comprising one or more antifusogenic peptides and an anti-CCR5 antibody (mAb CCR5) characterized in that one to eight antifusogenic peptides are each conjugated to one terminus of the heavy and/or light chains of the anti-CCR5 antibody and to the pharmaceutical use of the conjugate.